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pen accessAbstract Background: The use of transforaminal epidural injections under ﬂuoroscopy guaran-
tees the proper delivery of steroids to the target site with the least volume. The aim of this study
was to compare the effects of different volumes of epidural steroid injections for treatment of sci-
atica through transforaminal approach.
Methods: 60 ASA I–II patients complaining of unilateral radiculopathy were divided randomly
into three equal groups (group A–C), to be given transforaminal injection under ﬂuoroscopy. All
patients received a mixture of (80 mg methylprednisolone acetate + 1 ml contrast dye of Omni-
paque 300) plus 1 ml of 0.5% bupivacaine (group A), or 2 ml of 0.5% bupivacaine (group B), or
3 ml of 0.5% bupivacaine (group C).
Results: There was signiﬁcant reduction in the (VAS) score, at 60 minutes (group A 2.3 ± 1.1,
group B 2.7 ± 0.8 and group C 3 ± 0.8 p< 0.01). Patients in group A had signiﬁcantly lower
VAS score (3.9 ± 1) in relation to the groups B VAS score (4.7 ± 1.1) and C (5 ± 1.1) two weeks
after the injection (p< 0.01).
In group A, sixteen patients showed a signiﬁcant reduction in the frequency of analgesic intake in
the follow up period, while eleven patients reduced the frequency of analgesic intake during the 2om (A.M. Aref).
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62 A.M. Aref et al.weeks follow up period, in group B. As for group C, twelve patients remained on the same fre-
quency of analgesic intake following injection. Patients in group A showed signiﬁcant reduction
in the need for surgery.
Conclusion: Patients receiving a low volume and high concentration of corticosteroid via transfora-
minal epidural approach for the treatment of symptomatic lumbar disc herniation or spinal stenosis
had signiﬁcantly better short-term pain improvement, and less incidence of need for surgical inter-
vention, than patients who were treated with a diluted solution of corticosteroid.
ª 2011 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
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The purpose of an epidural steroid injection is to deliver corti-
costeroid close to the site of pathology, presumably onto an in-
ﬂamed nerve root, this is based on the principle that the
corticosteroid injected into the epidural space will have higher
local concentrations over an inﬂamed nerve root and will be
more effective than a steroid administered either orally or by
intramuscular injection [1].
One of the major concerns about epidural steroids is that
their true efﬁciency might not be evident in clinical trials be-
cause the injectate fails to reach the desired target. Thus, the
importance of transforaminal epidural injections under ﬂuo-
roscopy will guarantees the proper delivery of steroids to the
target site with the least volume, and fulﬁlling the aim of reach-
ing the primary site of pathology (ventral and lateral epidural
space), compared to interlaminar and caudal approaches.
Since pain generators are located anteriorly in the epidural
space, ventral epidural spread is the reasonable target for
placement of antiinﬂammatory medications [2–4].
There is no agreement on how epidural steroids injection
therapy should be done with respect to the volume and mass.
In addition, the methods used for epidural injections vary with
different physicians, and no standard for the performance of
this procedure has been deﬁned. Positive results from epidural
steroids vary from 20% to 95% and may depend on route of
injection [3,4]. We hypothesis that a higher concentration
which is delivered directly to the inﬂamed roots may have
more therapeutic effect than more diluted cortisone solution.
In spite of, the fact that it may have wider spread in the epi-
dural space.
The aim of this study was to compare the effects of different
volumes of epidural steroid injections for treatment of sciatica
through transforaminal approach.
2. Patients and methods
After approval from the Local Ethical Committee and written
informed consent, 60 ASA I–II patients were divided randomly
into three equal groups (group A–C) using the closed envelope
method. All patients had a thorough initial physical examina-
tion by the spine surgeon and the diagnosis of degenerative
lumbar disc herniation or foraminal spinal stenosis was con-
ﬁrmed by magnetic resonance imaging.
2.1. Inclusion criteria
Unilateral distribution of radicular pain, all patients should
have completed an anti-inﬂammatory course of medication
and physical therapy for at least six weeks without adequatebeneﬁt; both the patient and the treating surgeon have agreed
that operative treatment would have been the next indicated
step, after a trial of epidural steroid injection.2.2. Exclusion criteria
All patients who had had a previous spine operation, trauma,
cauda equina syndrome, a progressive neurological or a motor
deﬁcit, a neoplastic or infectious etiology, multiple disc lesions,
coagulation defect and a history of an adverse reaction to cor-
ticosteroids or local anesthetics.
All patients lied prone, sterile preparation was performed
with alcohol followed by Betadine (povidone–iodine) solu-
tion. Local superﬁcial anesthesia (1% lidocaine using a 25-
gauge needle), was injected into the skin at the lateral edge
and slightly inferior to the corresponding transverse pro-
cesses. With ﬂuoroscopic guidance, a 22-gauge spinal needle
was then advanced toward the junction between the trans-
verse processes and the superior articulating process till it
passed beneath the base of the appropriate pedicle. The ﬁnal
position of the tip of the needle was at the 6-O’clock posi-
tion of the pedicle on the antero posterior plane and the
12-O’clock position of the foramen on the lateral plane. This
target region is described as the safe triangle which is
bounded by the pedicle superiorly, the lateral border of
the vertebral body laterally, and the outer margin of the
spinal nerve medially [5–7].
When bloody tap occurred, the needle was repositioned to
obtain negative aspiration. To conﬁrm the correct position of
the needle tip 0.5–1 ml of contrast dye Omnipaque 300 was in-
jected to demonstrate the ﬂow around the nerve root. After
negative aspiration of ﬂuid or blood the steroid mixture was
given and then one ml contrast dye was injected and X-ray im-
age was taken (AP & lateral) to assess the spread of the
contrast.
Once appropriate needle placement had been conﬁrmed by
injecting 0.5–1 ml of contrast dye, all patients received a
mixture of (80 mg methylprednisolone acetate + 1 ml contrast
dye of Omnipaque 300 to display the distribution of the injec-
tant in the epidural space) plus 1 ml of 0.5% bupivacaine
(group A), or two milliliters of 0.5% bupivacaine (group B),
or 3 ml of 0.5% bupivacaine (group C).
X-ray images were taken after a contrast dye injection to
demonstrate the distribution within the epidural space,
showing the number of segments over which the injectate
had spread. The contrast ﬂow pattern was considered non-
selective where the dye spread to cover more than two nerve
roots, and/or crossed to the contralateral side. Using Visual
Analogue Scale (VAS: 0–10), all patients were asked to re-
port the degree of pain, before injection, 1 h after and after
Table 2 Showing visual analogue scale (VAS) and analgesic
intake.
Group A
(n= 20)
Group B
(n= 20)
Group C
(n= 20)
VAS mean (SD)
Pre-injection 6.5(0.8) 6(0.7) 7(0.5)
60 min 2.3(1.1)* 2.7(0.8) 3(0.8)
2 weeks 3.9(1)* 4.7(1.1) 5(1.1)
Analgesic intake 14 days (number of patients)
Decreased 16* 11 8
Unchanged 4 9 12
p< 0.01 within same group.
* p< 0.05 between group A, B and C.
Table 3 Showing number of injections, patients who had
surgery done and contrast ﬂow pattern.
Group A
(n= 20)
Group B
(n= 20)
Group C
(n= 20)
Injection (number of patients)
Single injection 12* 8 5
Two injections 6 9 6
Three injections 2 3 9
Surgery (number of patients)
Yes 2* 5 9
No 18 15 11
Contrast ﬂow pattern
(>2 roots and/or
crossing to other side)
15 18 20
* p< 0.05 between group A, B and C.
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that was blinded to the procedure. Six weeks after the injec-
tion, a follow up evaluation was performed in person or by
telephone. The procedure was considered a failure if, the pa-
tient showed no improvement after 2 weeks and demanded a
surgery. However; patients who showed partial improvement
were allowed up to 3 injections, with a minimum of 2 weeks
apart, using the former technique. The analgesic intake was
recorded 24 h after injection and 14 days following injection,
patients showing unchanged frequency of analgesic intake
before and after injection with a request for surgery were
considered to have a failed procedure.
3. Statistics
Statistical analysis was done using SPSS 16 program. Contin-
uous data was expressed as mean ± SD, for comparison of
parametric data one-way analysis of variance was applied.
Post hoc Student-Neuman-Keuls and Tukeys tests were used
to indicate which of the comparisons achieve statistical signif-
icance, for nonparametric data Kruskal–Wallis analysis was
applied. Chi-squared test was used for nominal data, Fisher
exact test was used for any values 5 or less. A P value
<0.05 was considered signiﬁcant.
4. Results
There were no signiﬁcant differences between groups with re-
gard to any of the demographic data and levels of disease
Table 1.
Pre-injection visual analogue scale (VAS) score showed non
signiﬁcant difference between the 3 groups, however, there was
signiﬁcant reduction in the (VAS) score, at 60 min (group A
2.3 ± 1.1, Group B 2.7 ± 0.8 and group C 3 ± 0.8
p< 0.01) Table 2.
Patients in group A had signiﬁcantly lower VAS score
(3.9 ± 1) in relation to the groups B VAS score (4.7 ± 1.1)
and C (5 ± 1.1) 2 weeks after the injection (p< 0.01) Table 2.
In group A, sixteen patients showed a statistically signiﬁ-
cant reduction in the frequency of analgesic intake in the fol-
low up period (p< 0.05) Table 2, while eleven patients
reduced the frequency of analgesic intake during the 2 weeks
follow up period, in group B. As for group C, twelve patients
remained on the same frequency of analgesic intake following
injection.
Group A showed a signiﬁcantly lower number of patients
(two) who decided to undergo surgery compared to 5 patientsTable 1 Demographic data and levels of disease.
Group A
(n= 20)
Group B
(n= 20)
Group C
(n = 20)
Age 49(15) 51(16) 45(12)
Weight (kilograms) 74(6) 76(8.5) 74(9)
Sex (female/male) 11/9 10/10 12/8
Disc level (patients number)
L3–L4 11 10 9
L4–L5 9 10 11
Presented as mean (SD) or number.in group B and 9 patients in group C (p< 0.05). Group A also
showed a signiﬁcantly higher number of patients (twelve) who
were satisﬁed with a single injection throughout the 6 weeks
follow up period, compared to 8 in group B and only 5 patients
in group C (p< 0.05) (Table 3).
Concerning the contrast ﬂow pattern, initial use of 0.5 ml
of contrast dye (Omnipaque 300) to conﬁrm the needle posi-
tion is considered selective to nerve root. However, the 3
groups were non-selective following injection of 2.5–4.5 ml
of steroid, dye and local anesthetic mixture, for the injectate
spread to more than 2 nerve roots and even crossed to the
contralateral side, there were no signiﬁcant difference be-
tween the 3 groups. In group A, ﬁfteen patients showed
non-selectivity, group B, eighteen patients showed non-selec-
tivity, as for C all the cases showed no selectivity to nerve
root.
Of the sixty patients in our study; none showed dural
puncture, however two patients complained of transient
headache following the injection, which resolved within
24 h. Only one patient suffered a vasovagal attack. Intravas-
cular placement of the needle during the epidural injection
has occurred in ten of the patients irrelevant to groups.
The incidence of complications was irrelevant to the group
of patients. During our short term follow up, none of the
patients showed complications related to epidural adminis-
tration of corticosteroids.
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In our study we were able to prove that a higher concentration
of corticosteroids (small volumes) directly delivered to the in-
ﬂamed roots through a transforaminal approach, had a more
therapeutic effect than diluted solutions (large volumes) for
treatment of sciatica, in spite of the fact that it may have wider
spread in the epidural space.
This may be explained by the presumption that injection of
higher concentrations of corticosteroids in a smaller volumemix-
ture, is considered therapeutically ‘‘selective’’ because it can deli-
ver the concentratedmedication to an anatomical spinal segment
or nerve root that correlates closely with the patient’s clinical and
radiographic examinations. The higher the volume the more the
likeliness of injectate dispersion and spread to the upper or lower
spinal segments or nerve roots and/or contralateral spread to the
opposite side, thus losing the therapeutic selectivity.
The most important ﬁnding was that 90% of the patients
who received high concentration corticosteroids in group A
didn’t require surgery versus 75% and 55% for high volume
groups B and C, respectively, after the 6 weeks follow up per-
iod. The analgesic intake in the form of anti-inﬂammatory
drugs for the high concentration group was signiﬁcantly re-
duced after 2 weeks and continued throughout the 6 weeks fol-
low up period, while in the high volume groups many patients
either remained on the same frequency of anti-inﬂammatory
intake before injection or resorted to surgery.
Our study supports that of Schaufele et al. [8] which also
stated that 90% of the patients injected with a high concentra-
tion mixture of 1 ml of 80 mg methylprednisolone acetate and
1 ml of lidocaine 2%, were satisﬁed with the injections and
didn’t require surgery later. In another study by Kabatas et
al. [9] where a mixture of (0.5 ml 0.5% bupivacaine + 1 ml
40 mg methylprednisolone + 1 ml Omnipaque 300 dye) were
injected, results showed that 67% of the cases didn’t need sur-
gery. Although a high concentration mixture was injected, the
percentage of patients asking for surgery here was higher than
ours, maybe because most of their patients suffered from
spinal stenosis which doesn’t improve signiﬁcantly following
TFESI. In a randomized controlled trial (RCT) by Riew et
al. [10] a mixture composed of 1 ml of 0.25% bupivacaine
and 6 mg of betamethasone in 1 ml was injected, 75% of the
patients decided not to have an operation post-injection, the
difference between their results and ours may be due to the
use of betamethasone acetate instead of methylprednisolone.
This is proved in a study by Noe and Haynsworth [11] showing
that the aqueous steroid betamethasone is not an effective
alternative to the commonly used methylprednisolone (Depo-
Medrol) when injected epidurally in patients with lumbar pain.
The study also shows that the anti-inﬂammatory effect of a
depo-steroid can be greater than a non-depo steroid, even at
equipotent doses. This should be an important factor to con-
sider when reviewing epidural steroid outcome studies, where
the type of steroid might affect results as much as other vari-
ables such as route of administration, volume of injectate, or
use of ﬂuoroscopy.
As for other studies which looked at the outcome of trans-
foraminal epidural steroid injection; Vad et al. [12] transforami-
nally injected a total volume of 1.5 ml betamethasone acetate
(9 mg) + 1.5 ml of 2% preservative free xylocaine, with an out-
come of 85% of patients not reverting to surgery, in a study byLutz et al. [13], with 1.5 ml of 2% xylocaine and 1.5 ml 9 mg of
betamethasone acetate injected a successful outcome with no
surgery was reported by 52 of the 69 patients (only 75.4%) at
an average follow-up of 80 weeks (range 28–144 weeks). On
the contrary, in a study by Weiner and Fraser [14] 28 patients
with severe radiculopathy secondary to herniation of lumbar
disks were treated by transforaminal steroid injection, using a
large volume of injectate 2 ml of 1% lidocaine combined with
2 ml of betamethasone. The authors showed that 22 of the 28
patients improved dramatically, with sustained long term relief
lasting for 3 years. In their studies 89% of the patients didn’t
request for surgery, while in our study, only 55% of the patients
from group C with the large volume injectate didn’t require sur-
gery, this difference was presumably because their cases had a
lower VAS score than ours pre-injection.
Another study by Botwin et al. [15] involving the injection
of a solution of 2 ml of 1% xylocaine + 2 ml (12 mg) beta-
methasone acetate revealed the following, 61.8% of their pa-
tients didn’t consider surgery in a short term follow up of 2
months. While our study also showed a signiﬁcant improve-
ment in the VAS score in the 2 weeks follow up period con-
cerning group A in comparison with groups B and C.
The study by Schaufele et al. [8], also gave VAS score results
similar toour studyas therewas a statistically signiﬁcant improve-
ment in the VAS scores from before the injection (VASmean 5.9)
to VAS after injection in the follow up period (VAS mean 3.2,
p< 0.01), in our study it was 6(0.8) before versus 3.9(1) 2 weeks
after injection, both studies were done for patients injected with
a high concentration steroid/local anesthetic mixture (2 ml).
As for the number of injections 45% of Schaufele’s [8] cases
were satisﬁed with a single injection compared to 60% of our
group A patients. In groups B and C only 40% and 25%,
respectively were satisﬁed with a single injection in our study.
Transforaminal epidural injections of anesthetic and corti-
costeroids are generally safe with a reported minor complica-
tion rate of 9.6% in the lumbar spine [16].
Considering procedural complications, of our 60 patients
there was no incidence of infection, dural puncture or compli-
cations related to epidural injection of corticosteroids. How-
ever post injection headache occurred in 3% of our patients,
vasovagal attack had a 1.6% incidence and intravascular
placement of the needle 17%.
In a study by Botwin et al. [16] complications were reported
including transient headaches in 3.1% and vasovagal reaction
in 0.3%. Furman et al. [17] reported an overall rate of intra-
vascular injection of 11.2% compared to 8.3% in our study.
Manchikanti et al. [18] reported intravenous placement of
the needle in 22% of the procedures, and the same incidence
of headaches as our study of 3%. In a prospective study by
Lee et al. [19], 87 ﬂuoroscopically guided injections, the inci-
dence of intravascular injections during lumbosacral transfora-
minal ESIs as determined by digital subtraction ﬂuoroscopic
guidance was 23% overall.
The limitations of our study: First, the follow-up interval for
pain improvement was short (only 6 weeks). However, it is com-
monly agreed that epidural steroid injections are particularly
helpful for pain control in the ﬁrst weeks after the injection.
Second, the sample size was relatively small plus the strict
inclusion/exclusion criteria that were enrolled. This eliminated
a large proportion of patients typically seen by pain interven-
tionalists. Our goal was to limit the study to a certain group of
patients to increase our results validity.
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